Passage BIO, Inc.·4

May 30, 7:26 PM ET

Kassberg Thomas Richard 4

4 · Passage BIO, Inc. · Filed May 30, 2025

Insider Transaction Report

Form 4
Period: 2025-05-28
Transactions
  • Award

    Director Stock Option (right to buy)

    2025-05-28+143,789143,789 total
    Exercise: $0.36Exp: 2035-05-28Common Stock (143,789 underlying)
Footnotes (1)
  • [F1]The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2026 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.

Documents

1 file
  • 4
    form4-05302025_110528.xmlPrimary